Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | JAK2 | O60674 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.55 |
| ▸ | HPGD | P15428 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MITF | O75030 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | GSTO1 | P78417 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL917057 | 0.87 | POLB (0.50) | ALDH1A1MAPTSMN1; SMN2HPGDKMT2A | |
| SCHEMBL917591 | 0.85 | POLB (0.49) | ALDH1A1MAPTJAK2SMN1; SMN2HPGD | |
| SCHEMBL16499804 | 0.83 | ALDH1A1 (0.49) | ALDH1A1MAPTSMN1; SMN2KMT2APKM | |
| SCHEMBL29417999 | 0.79 | POLB (0.76) | ALDH1A1MAPTJAK2SMN1; SMN2HPGD | |
| SCHEMBL6030738 | 0.79 | POLB (0.76) | ALDH1A1MAPTJAK2SMN1; SMN2HPGD | |
| SCHEMBL917175 | 0.77 | ALDH1A1 (0.55) | ALDH1A1MAPTJAK2SMN1; SMN2HPGD | |
| SCHEMBL6570247 | 0.76 | ALDH1A1 (0.69) | ALDH1A1MAPTJAK2SMN1; SMN2HPGD | |
| SCHEMBL4006392 | 0.76 | HPGD (0.69) | ALDH1A1MAPTSMN1; SMN2HPGDKMT2A | |
| SCHEMBL10369646 | 0.75 | KMT2A (0.68) | ALDH1A1MAPTJAK2SMN1; SMN2HPGD | |
| SCHEMBL7081917 | 0.73 | NPC1 (0.61) | ALDH1A1MAPTJAK2SMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1803712-B1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2015-12-30 | — | — | EP | disclosed |
| US-7872036-B2 | 3-triazolylphenyl sulfide derivative and insecticide, miticide and nematicide containing it as an active ingredient | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20090076282-A1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO., LTD (JP) | 2009-03-19 | — | — | US | disclosed |
| EP-1803712-A1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076282-A1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | CBR3, CBS, AHCYL1 | ALDH1A1 1024/4885MAPT 2783/4885JAK2 2545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.